Disulfiram Pathway, Pharmacodynamics (Dopaminergic neuron)

Pathway network for the Disulfiram Pathway, Pharmacodynamics (Dopaminergic neuron) SuperPath

Sources:
  • PharmGKB
  • WikiPathways

Gene overlap in member pathways for Disulfiram Pathway, Pharmacodynamics (Dopaminergic neuron) SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Disulfiram Pathway, Pharmacodynamics (Dopaminergic neuron) SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Alcohol dependenceEnrichmentADH1B, ALDH25.23
2Ellis-van creveld syndromeEnrichmentPRKACA, PRKACB4.52
3Brunner syndromeEnrichmentMAOA3.29
4Alcohol sensitivity, acuteEnrichmentALDH23.29
5Catechol-o-methyltransferase activity, variation inEnrichmentCOMT3.29
6Albinism, oculocutaneous, type ibEnrichmentTYR3.02
7Skin/hair/eye pigmentation, variation in, 3EnrichmentTYR3.02
8Cardioacrofacial dysplasia 2EnrichmentPRKACB3.02
9Pigmented nodular adrenocortical disease, primary, 4EnrichmentPRKACA3.02
10Cardioacrofacial dysplasia 1EnrichmentPRKACA3.02
11Minimal pigment oculocutaneous albinism type 1EnrichmentTYR3.02
12Hypopigmentation of the skinEnrichmentTYR3.02
13Segawa syndrome, autosomal recessiveEnrichmentTH2.99
14Aromatic l-amino acid decarboxylase deficiencyEnrichmentDDC2.99
15Amed syndrome, digenicEnrichmentALDH22.99
16Major affective disorder 1EnrichmentTPH22.88
17Dystonia, dopa-responsiveEnrichmentTH2.81
18Bleeding disorder, platelet-type, 19EnrichmentPRKACG2.72
19Albinism, oculocutaneous, type iaEnrichmentTYR2.72
20Melanoma, cutaneous malignant 8EnrichmentTYR2.72
21Fibrolamellar carcinomaEnrichmentPRKACA2.72
22Spastic tetraplegia and axial hypotonia, progressiveEnrichmentSOD12.72
23Houge-janssens syndrome 3EnrichmentPPP2CA2.72
24Major depressive disorderEnrichmentTPH22.48
25Amyotrophic lateral sclerosis 10 with or without frontotemporal dementiaEnrichmentSOD12.32
26Albinism, ocular, type iEnrichmentTYR2.24
27AlbinismEnrichmentTYR2.24
28Digeorge syndromeEnrichmentCOMT2.21
29Crigler-najjar syndrome, type iEnrichmentUGT1A62.18
30Hyperbilirubinemia, transient familial neonatalEnrichmentUGT1A62.18
31Bilirubin, serum level of, quantitative trait locus 1EnrichmentUGT1A62.18
32Crigler-najjar syndrome, type iiEnrichmentUGT1A62.18
33Waardenburg syndrome, type 2eEnrichmentTYR2.17
34Oculocutaneous albinismEnrichmentTYR2.17
35Motor neuron diseaseEnrichmentSOD12.17
36Gilbert syndromeEnrichmentUGT1A62.14
37Bilirubin metabolic disorderEnrichmentUGT1A62.14
38Amyotrophic lateral sclerosis 1EnrichmentSOD12.02
39Optic nerve diseaseEnrichmentTYR2.02
40RasopathyEnrichmentDDC1.87
41MyopiaEnrichmentTYR1.85
42DystoniaEnrichmentTH1.75
43Skin diseaseEnrichmentTYR1.68
44Bardet-biedl syndromeEnrichmentCOMT1.67
45StrabismusEnrichmentTYR1.59
46SchizophreniaEnrichmentCOMT1.52
47Eye diseaseEnrichmentTYR1.48
48Frontotemporal dementia and/or amyotrophic lateral sclerosis 7EnrichmentSOD11.27
49Complex neurodevelopmental disorderEnrichmentPPP2CA0.95

Loading...
Loading...
Loading...